Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060788

President & CEO acquired 94,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-12-12 Grant or award +94,100 393,319 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBIN HOWARD W President & CEO 2019-12-12 Grant or award · Stock Option +167,650 167,650 D: show line 2 in the form
ROBIN HOWARD W President & CEO 2019-12-12 Grant or award · Stock Option +44,600 44,600 D: show line 3 in the form
Loading xslF345X03/doc4.xml…